Versameb Strengthens its Board of Directors

/PRNewswire/ -- Versameb AG ("Versameb"), transforming (m)RNA therapeutics to cure hard-to-treat and/or prevalent diseases, is pleased to announce the...

Related Keywords

London ,City Of ,United Kingdom ,Buenos Aires ,Distrito Federal ,Argentina ,Tauris ,Rhôalpes ,France ,Switzerland ,Paris ,France General ,Klaas Zuideveld ,Paul Korner ,Brevan Howard ,Lily Geidelberg ,Alexandre Lebeaut ,Novartis ,Plough Research Institute ,University Of Buenos Aires ,Paris Diderot University ,Ferring Pharmaceuticals ,Paris Descartes University ,Imperial College London ,Axcan Pharmaceuticals ,Clinical Medical Affairs At Axovant Gene Therapies ,Linkedin ,Institute For Advanced Clinical Trials Children ,Schering ,Ardelyx Inc ,Stress Urinary Incontinence ,Chief Executive Officer ,Senior Biotechnology Analyst ,Sarepta Therapeutics ,Axovant Gene ,Chief Medical Officer ,Medical Affairs ,Axovant Gene Therapies ,Laidlaw Venture Partners ,Schering Plough Research Institute ,Chief Scientific Officer ,Advanced Clinical Trials ,Calypso Biotech ,Paris Descartes ,